Indacaterol maleate is a maleate salt obtained by reaction of indacaterol with one equivalent of maleic acid. Used for treatment of chronic obstructive pulmonary disease. Among its listed roles, it functions as a beta-adrenergic agonist and a bronchodilator agent. It includes a indacaterol. It is grouped under the following drug class(es): Beta-2 agonists and Bronchodilators. Its therapeutic use is listed as anti-asthmatic agents. The directory classifies it as a commercial API with a biotechnology source/manufacturing origin. Other names for this substance include Arcapta Neohaler and Oslif Breezhaler. Its PubChem CID is 9827599.
Indacaterol maleate
| CAS No | 753498-25-8 |
|---|---|
| Molecular Formula | C28H32N2O7 |
| Molecular Weight | 508.6 g/mol |
| Synonyms | (Z)-but-2-enedioic acid;5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Indacaterol maleate is a maleate salt obtained by reaction of indacaterol with one equivalent of maleic acid. Used for treatment of chronic obstructive pulmonary disease.
The listed CAS number is 753498-25-8.
The listed molecular formula is C28H32N2O7.
The listed molecular weight is 508.6 g/mol.
(Z)-but-2-enedioic acid;5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one.
The source lists Arcapta Neohaler and Oslif Breezhaler.